Chelsea Therapeutics (CHTP) is a development stage pharmaceutical company that focuses on acquiring, developing and commercializing products for the treatment of a variety of human diseases. This stock is trading up 63% at $3.94 in recent trading.
Today's Range: $3.60-$4.0352-Week Range: $2.18-$6.06 Volume: 14.3 million Three-Month Average Volume: 1.2 million >>6 Drug Stocks Unworthy of a Biotech Bull Market Shares of CHTP are soaring huge today after a committee of independent experts recommended the approval of its hypotension drug in the U.S. The FDA panel voted 7 to 4 in favor of the drug's approval on Thursday. This move will now be taken into consideration by the FDA, which is expected to vote on the drug by March 28. From a technical perspective, CHTP is gapping up huge today on monster volume. Market players should continue to look for long-biased trades in CHTP as long as the stock remains above $3.83 to $3.60. That $3.83 level is a near-term breakout level, and that $3.60 level is today's low price. If CHTP can continue to trend above those key technical levels with strong volume, then this stock has a great chance to tag $4.60 (its 200-day moving average) to $4.63 (its 50-day), or possibly even higher. Keep in mind that CHTP traded as high as $5.74 back in early December. Follow @stockpickr
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV